Spectrum bias: Why generalists and specialists do not connect

Evidence-Based Medicine

Volumn 13, Issue 5, 2008, Pages 132-133

  Jelinek, Michael ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPNEA; ECG ABNORMALITY; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; EXERCISE TEST; GENERAL PRACTITIONER; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL SPECIALIST; MITRAL VALVE PROLAPSE; MORTALITY; PATIENT REFERRAL; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; ST SEGMENT DEPRESSION; SUDDEN DEATH; THORAX PAIN; EPIDEMIOLOGY; MEDICINE;

BIAS (EPIDEMIOLOGY); CORONARY ARTERY DISEASE; HUMANS; PHYSICIANS, FAMILY; SPECIALTIES, MEDICAL;

EID: 53249097852     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.13.5.132     Document Type: Article

References (25)

1. Joseph A, Ackerman D, Talley JD, et al. Manifestations of coronary atherosclerosis in young trauma victims - an autopsy study. J Am Coll Cardiol 1993;22 459-67.
2. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
3. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Eng J Med 1978; 299:926-30.
4. Philbrick JT, Horwitz RI, Feinstein AR. Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias. Am J Cardiol 19B0;46:807-12.
5. Rozanski A, Diamond GA, Berman D, et al. The declining specificity of exercise radionuclide ventriculography. N Eng J Med 1983;309:518-22.
6. Morise AP, Diamond GA. Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 1995;130:741-7.
7. Cecil MP, Kosinski AS, Jones MT, et al. The importance of work-up (verification) bias in assessing the accuracy of SPECT thallium-201 testing for the diagnosis of coronary artery disease. J Clin Epidemiol 1996;49:735-42.
8. Roger VL, Pellikka PA, Bell MR, et al. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation 1997;95:405-10.
9. Miller TD, Hodge DO, Christian TF, et al. Effects of adjustment for referral bias on the sensitivity and specificity of single photon emission computed tomography for the diagnosis of coronary artery disease. Am J Med 2002;112:290-7.
10. Diamond GA. Reverend Bayes' silent majority. An alternative factor affecting sensitivity and specificity of exercise electrocardiography. Am J Cardiol 1986;5:1175-80.
11. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39:207-15.
12. Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Eng J Med 1985;313:1305-9.
13. Duren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse: a prospective study. J Am Coll Cardiol 1968;11:42-7.
14. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Eng J Med 1999;341:1-7.
15. McKenna W, Deanfield J, Faruqui A, et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-8.
16. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000; 102:858-64.
17. Ellestad MH, Wan MK. Predictive implications of stress testing. Follow-up of 2700 subjects after maximum treadmill stress testing. Circulation 1975;51:363-9.
18. Dagenais GR, Rouleau, Christen A, et al. Survival of patients with a strongly positive exercise electrocardiogram. Circulation 1982;65:452-6.
19. Podrid PJ, Graboys TB, Lown B. Prognosis of medically treated patients with profound ST-segment depression during exercise testing. N Eng J Med 1981;305:1111-6.
20. Jelinek M. Clinical epidemiology: a deconstruction. Intern Med J 2005;35:104-5.
21. Christopher Jones R, Pothier CE, Blackstone EH, et al. Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease. Am J Med 2004;117:380-9.
22. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
23. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Eng J Med 2002;347:161-7.
24. Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003;108:2950-3.
25. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Eng J Med 1979; 300:1350-8.